12 results · 20ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

REGEN Bioactive Cement

FDA 510(k)
FDA Class 2 ·Dental

RZ Medizintechnik GmbH

FDA UDI
RZ-Medizintechnik GmbH·04049197182249·Dittel-Bougies, slightly curved, 35.5 c...

RZ Medizintechnik GmbH

FDA UDI
RZ-Medizintechnik GmbH·04049197182232·Dittel Dilating Bougies Charr....

Corvocet Biopsy System

FDA 510(k)
FDA Class 2 ·Gastroenterology, Urology

DIMENSION URINE ECSTASY SCREEN FLEX REAGENT CARTRIDGE, MODEL DF 109

FDA 510(k)
FDA Class 2 ·Clinical Toxicology

VANGUARD CRUCIATE RETAINING TIBIAL BEARING 10MM X 63/67MM

FDA Adverse Event
Injury ·ZIMMER BIOMET, INC.·Product code JWH·December 5, 2025

VERSYS FEMORAL STEM

FDA Adverse Event
Injury ·ZIMMER INC·Product code LPH·February 25, 2016

ASR UNI FEMORAL IMPL SIZE 45

FDA Adverse Event
Injury ·DEPUY INTERNATIONAL·Product code KWA·September 19, 2011

GRANUFLO

FDA Adverse Event
Death ·FRESENIUS MEDICAL CARE NORTH AMERICA·Product code KPO·November 7, 2014

UNKNOWN DEPUY ASR ACETABULAR CUP

FDA Adverse Event
Injury ·DEPUY INTL., LTD. - 8010379·Product code KWA·July 29, 2013

TRUE METRIX

FDA Adverse Event
Malfunction ·TRIVIDIA HEALTH INC·Product code NBW·December 30, 2019

Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014